Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01473251
What this trial is testing

Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

Who this might be right for
Exudative Macular DegenerationDiabetic Macular Edema
Vitreo-Retinal Associates, Michigan 16
Not applicableStudy completedNCT00379795
What this trial is testing

An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO

Who this might be right for
Choroidal Neovascularization, Age-related Macular Degeneration
Genentech, Inc. 853
Early research (Phase 1)Ended earlyNCT04594681
What this trial is testing

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Healthy VolunteersWet Age-related Macular Degeneration
Kyowa Kirin Co., Ltd. 116
Testing effectiveness (Phase 2)Study completedNCT02288559
What this trial is testing

Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Genentech, Inc. 96
Not applicableStudy completedNCT01805323
What this trial is testing

A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema

Who this might be right for
Macular Edema
Allergan 101
Post-approval studies (Phase 4)Study completedNCT01542190
What this trial is testing

Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery

Who this might be right for
Cystoid Macular Edema Following Cataract Surgery, Bilateral
University of Campinas, Brazil 80
Not applicableStudy completedNCT04714424
What this trial is testing

Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues

Who this might be right for
PtosisMacular DegenerationAmetropia
Icahn School of Medicine at Mount Sinai 84
Early research (Phase 1)Study completedNCT00943982
What this trial is testing

The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma

Who this might be right for
Uveitis
National Eye Institute (NEI) 5
Testing effectiveness (Phase 2)Ended earlyNCT00668785
What this trial is testing

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)

Who this might be right for
Proliferative Diabetic RetinopathyMacular Edema
Jumper, J. Michael, M.D. 6
Not applicableStudy completedNCT03946085
What this trial is testing

Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)

Who this might be right for
Retinal DrusenAge-related Macular DegenerationMacular Degeneration
Guardion Health Sciences, Inc. 79
Not applicableNot Yet RecruitingNCT07409389
What this trial is testing

Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration

Who this might be right for
AMD - Age-Related Macular Degeneration
The Hong Kong Polytechnic University 94
Not applicableStudy completedNCT06860568
What this trial is testing

The GA in HSI Study

Who this might be right for
Geographic AtrophyHealthy
Optina Diagnostics Inc. 42
Not applicableStudy completedNCT01942213
What this trial is testing

Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.

Who this might be right for
Neovascular Age Related Macular Degeneration
Prism Vision Group 136
Testing effectiveness (Phase 2)Study completedNCT00782717
What this trial is testing

A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients

Who this might be right for
Macular Edema
Alcon Research 263
Testing effectiveness (Phase 2)Study completedNCT03815825
What this trial is testing

GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationGeographic Atrophy
Ionis Pharmaceuticals, Inc. 332
Not applicableWithdrawnNCT05675917
What this trial is testing

MacuTest Website for Personalized AMD Risk Prediction and Prevention

Who this might be right for
Macular Degeneration
University Hospital, Bordeaux
Not applicableNot Yet RecruitingNCT07821450
What this trial is testing

Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study

Who this might be right for
BlepharoptosisAge-Related Macular DegenerationDiabetic Macular Edema
Abdulkadir Küçük 60
Testing effectiveness (Phase 2)Study completedNCT03499223
What this trial is testing

Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)

Who this might be right for
Diabetes MellitusDiabetic RetinopathyMacular Edema
Oxurion 70
Testing effectiveness (Phase 2)Study completedNCT01298076
What this trial is testing

Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

Who this might be right for
Diabetic RetinopathyMacular Edema
University of Sydney 61
Not applicableLooking for participantsNCT03752840
What this trial is testing

Village-Integrated Eye Worker Trial II

Who this might be right for
Age-related Macular DegenerationDiabetic RetinopathyGlaucoma
University of California, San Francisco 60,200
Next Page